Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01558102 · ClinicalTrials.gov registry record
International Retrospective Study of Pipeline Embolization Device
A clinical trial, sponsored by Medtronic Neurovascular Clinical Affairs.
- Completed
- Registry status
- 793
- Enrollment target
NCT01558102: Completed study, sponsored by Medtronic Neurovascular Clinical Affairs.
NCT01558102 is a clinical trial that has completed, run by Medtronic Neurovascular Clinical Affairs. The registered enrollment target is 793 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01558102 has completed, sponsored by Medtronic Neurovascular Clinical Affairs.
- COMPLETED
- Registry status
- 793 participants
- Enrollment target
Study Summary
The primary objective of this retrospective study is to determine the incidence of important safety outcomes in patients who have undergone Pipeline Embolization Device placement for intracranial aneurysms (IAs). This study does not effect patient care, simply it is designed to observe and capture information from numerous hospitals. Data collection will be initiated starting March 2012 and continue until approximately April 2017.
Primary Outcome
Incidence of neurologic events from the time of Approval of the Pipeline Embolization Device in the country of use until IRB approval at facility.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 793 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-07 |
What the finished NCT01558102 record still lists
NCT01558102 is an observational study that tracks outcomes without assigning an intervention. The registered 793 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01558102 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01558102 about?
NCT01558102 is a clinical study titled "International Retrospective Study of Pipeline Embolization Device". The primary objective of this retrospective study is to determine the incidence of important safety outcomes in patients who have undergone Pipeline Embolization Device placement for intracranial aneurysms (IAs). This study does not effect patient care, simply it is designed to observe and capture i...
What is the current status of trial NCT01558102?
This trial is currently completed. The enrollment target is 793 participants. The study started on 2012-03. Estimated completion is 2013-07.
Who is sponsoring clinical trial NCT01558102?
This trial is sponsored by Medtronic Neurovascular Clinical Affairs, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03424005 · 792 participants · Phase 1
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- NCT05866081 · 792 participants · NA
Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative
- NCT06722352 · 792 participants · NA
Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)
- NCT06208150 · 795 participants · Phase 3
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia